Back to User profile » Prof. Dr. Bjorn Gudbjornsson

Paper published by Prof. Dr. Bjorn Gudbjornsson:


Original Research

Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registry

Gudbjornsson B, Geirsson AJ, Krogh NS

Psoriasis: Targets and Therapy 2018, 8:13-19

Published Date: 4 May 2018